Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00905 | Propargyl-PEG5-t-butyl ester | 1245823-50-0 |
| Inquiry | ||
| BADC-00907 | Bis-PEG8-acid | 1246189-43-4 |
| Bis-PEG8-acid is a PEG linker containing two terminal carboxylic acid groups. The terminal carboxylic acids can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. The hydrophilic PEG spacer increases solubility in aqueous media. | Inquiry | |
| BADC-00908 | DBCO-amine | 1255942-06-3 |
| Inquiry | ||
| BADC-00909 | DBCO-NH-PEG4-amine | 1255942-08-5 |
| Inquiry | ||
| BADC-00910 | DBCO-NHCO-PEG4-NH-Boc | 1255942-12-1 |
| Inquiry | ||
| BADC-00911 | Azido-PEG4-propionic acid | 1257063-35-6 |
| Azido-PEG4-acid is a PEG-based PROTAC linker used in the synthesis of PROTACs. It is also a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00912 | t-Boc-N-amido-PEG1-propionic acid | 1260092-44-1 |
| t-Boc-N-amido-PEG1-propionic acid is a cleavable (1-unit PEG) ADC linker, as well as a PEG- and alkyl/ether-based PROTAC linker that can be used to synthesize antibody-drug conjugates (ADCs) or PROTACs. | Inquiry | |
| BADC-00913 | Bis-PEG9-acid | 1268488-70-5 |
| Bis-PEG9-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. Bis-PEG9-acid is also a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00914 | Tr-PEG6-OH | 127999-16-0 |
| Tr-PEG6-OH is a PROTAC linker (belonging to the PEG class) that can be used to synthesize PROTAC molecules. Tr-PEG6-OH is also a non-cleavable 6-unit PEG ADC linker that is used in the synthesis of antibody-conjugated drugs (ADCs). | Inquiry | |
| BADC-00915 | Amino-PEG6-t-butyl ester | 1286281-32-0 |
| NH2-PEG6-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. NH2-PEG6-Boc is also a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00916 | t-Boc-N-amido-PEG7-alcohol | 1292268-13-3 |
| N-Boc-PEG7-alcohol is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00917 | Amino-PEG10-alcohol | 129449-09-8 |
| Amino-PEG10-OH is non-cleavable 10 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00918 | Aminooxy-PEG3-azide | 1306615-51-9 |
| Aminooxy-PEG3-azide is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Aminooxy-C2-PEG3-azide is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. | Inquiry | |
| BADC-00919 | Propargyl-PEG4-Br | 1308299-09-3 |
| Propargyl-PEG4-Br is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00920 | m-PEG4-Ms | 130955-37-2 |
| m-PEG4-Ms is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00921 | m-PEG5-Ms | 130955-38-3 |
| m-PEG5-Ms is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00922 | Bis-PEG2-PFP ester | 1314378-18-1 |
| Bis-PEG2-PFP ester is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Bis-PEG2-PFP ester is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. | Inquiry | |
| BADC-00923 | Azido-PEG7-amine | 1333154-77-0 |
| Azido-PEG7-amine is a non-cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00924 | Bis-PEG7-NHS ester | 1334170-02-3 |
| Bis-PEG7-NHS ester is a non-cleavable 7-unit PEG linker that can be used to synthesize antibody-conjugated drugs (ADCs). | Inquiry | |
| BADC-00925 | Tr-PEG3-OH | 133699-09-9 |
| Tr-PEG3-OH is a PROTAC linker (belonging to the PEG class) that can be used to synthesize PROTAC molecules. Tr-PEG3-OH is also a non-cleavable 3-unit PEG ADC linker that is used in the synthesis of antibody-conjugated drugs (ADCs). | Inquiry |
